09. 11(Thu)
09. 11(Thu) 13:00~14:30 Room 4
Lipid Metabolism at the Crossroads of Inflammation, Toxicity, and Atherosclerosis
- From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events 13:00~13:20
- Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions 13:20~13:40
- Lipidomics based understanding of human disease 13:40~14:00
- Panel Discussion 14:00~14:30
09. 11(Thu) 14:40~16:10 Room 4
Redefining Cardiovascular Care: PCSK9 Mechanisms and siRNA-Based Advances
- Deep dive into PCSK9: the master regulator of LDL metabolism and inflammation 14:40~15:00
- siRNA-based lipid therapies: a revolution in cholesterol management 15:00~15:20
- Expanding the horizons: siRNA applications beyond LDL cholesterol in cardiovascular disease 15:20~15:40
- Panel Discussion 15:40~16:10
09. 11(Thu) 16:20~17:50 Room 4
Socioeconomic Status: The Missing Piece in Cardiovascular Risk Stratification
09. 12(Fri)
09. 12(Fri) 08:30~10:00 Room 4
TBD
09. 12(Fri) 13:00~14:30 Room 4
Defining the Optimal LDL-C Target for Prevention of Atherosclerotic Cardiovascular and Cerebrovascular Disease
- Optimal LDL-C goals for secondary prevention in high-risk patients - a cardiologist’s perspective 13:00~13:20
- Optimal LDL-C level for stroke prevention - insights from a neurologist’s perspective 13:20~13:40
- Different LDL-C targets by duration of diabetes: what is the evidence? - an endocrinologist’s perspective 13:40~14:00
- Panel Discussion 14:00~14:30
09. 12(Fri) 16:45~18:15 Room 4
Emerging Complexities in Adipose Tissue Metabolism and Physiology
09. 13(Sat)
09. 13(Sat) 07:50~08:50 Room 4
09. 13(Sat) 08:50~10:20 Room 4
From Treatment to Prevention: A Paradigm Shift in Obesity
09. 13(Sat) 16:20~17:50 Room 4
The Impact of Remnant Cholesterol on Various Disease Pathologies and Clinical Outcomes
- Remnant cholesterol as a key contributor to atherosclerotic cardiovascular disease (ASCVD): mechanisms and clinical implications 16:20~16:40
- The role of remnant cholesterol in chronic kidney disease (CKD) progression and cardiovascular risk 16:40~17:00
- Association between remnant cholesterol and dementia: potential mechanisms and clinical perspectives 17:00~17:20
- Panel Discussion 17:20~17:50
